title: From bench to bedside: promising colon cancer clinical trials.
authors: University of Louisiana at Monroe College of Pharmacy-Shreveport Campus, 1725 Claiborne Ave, Shreveport, LA 71103, USA. comeau@ulm.edu
authors: Jill M
authors: JM
authors: Comeau
authors: Brice
authors: B
authors: Labruzzo Mohundro
mesh_terms: D000409:Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D004317:Doxorubicin / Q000737:chemistry; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006979:Hyperthermia, Induced; D000077341:Lapatinib; D008081:Liposomes / Q000737:chemistry; D009536:Niacinamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011759:Pyrrolidines; D011799:Quinazolines / Q000627:therapeutic use; D000077157:Sorafenib; D013941:Thymine; D059004:Topoisomerase I Inhibitors / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D014271:Trifluridine / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000096662:Ramucirumab
chemical_list: D000409:Alanine; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001549:Benzamides; D019496:Cancer Vaccines; D004317:Doxorubicin; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000077341:Lapatinib; D008081:Liposomes; D009536:Niacinamide; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011759:Pyrrolidines; D011799:Quinazolines; D000077157:Sorafenib; D013941:Thymine; D059004:Topoisomerase I Inhibitors; D014227:Triazines; D014271:Trifluridine; D014498:Uracil; D000096662:Ramucirumab; C573235:FANG vaccine; C000613803:trifluridine tipiracil drug combination; C118739:entinostat; C509922:brivanib